Back to Trades
JOHNSON JOHN
DirectorCIK 0001410781
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 3
- Active
- 2025–2026
Across 7 filings between 2025–2026, JOHNSON JOHN, Director, has disclosed $3.7M in transactions — spread across 3 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $3.2M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 26 | AXGN Axogen, Inc. | JOHNSON JOHN | Director | Award | $0 |
| Jun 23 | AXGN Axogen, Inc. | JOHNSON JOHN | Director | Exercise | $0 |
| Jun 5 | XERS Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Director | Sell | $91.4K |
| May 26 | VSTM Verastem, Inc. | JOHNSON JOHN | Director | Grant | $0 |
| Dec 19 | XERS Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Director | Sell | $977.0K |
| Dec 10 | AXGN Axogen, Inc. | JOHNSON JOHN | Director | Sell | $1.4M |
| Aug 15 | XERS Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Director | Sell | $786.5K |
7 filings